Glycerol-3-Phosphate Dehydrogenase: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 38: | Line 38: | ||
GlpD is involved in diseases such as Alzeheimer`s, muscle dystrophy, hyaline membrane diseases and many more. | GlpD is involved in diseases such as Alzeheimer`s, muscle dystrophy, hyaline membrane diseases and many more. | ||
==3D structures of glycerol-3-phosphate dehydrogenase== | |||
[[Glycerol-3-phosphate dehydrogenase 3D structures]] | |||
</StructureSection> | </StructureSection> | ||
==3D structures of glycerol-3-phosphate dehydrogenase== | ==3D structures of glycerol-3-phosphate dehydrogenase== | ||
| Line 55: | Line 59: | ||
*NADPH-dependent GPDH | *NADPH-dependent GPDH | ||
** | **[[1x0x]] – hGPDH + NAD – human<br /> | ||
**[[1wpq]] - hGPDH + NAD + DHA<br /> | **[[1wpq]] - hGPDH + NAD + DHA<br /> | ||
**[[1x0v]] – hGPDH<br /> | **[[1x0v]] – hGPDH<br /> | ||
| Line 65: | Line 68: | ||
**[[1n1g]], [[1m66]], [[1m67]], [[1jdj]] – LmGPDH + inhibitor<br /> | **[[1n1g]], [[1m66]], [[1m67]], [[1jdj]] – LmGPDH + inhibitor<br /> | ||
**[[1evz]] - LmGPDH + NAD<br /> | **[[1evz]] - LmGPDH + NAD<br /> | ||
**[[1n1e]] – LmGPDH + NAD + DHAP | **[[1n1e]] – LmGPDH + NAD + DHAP<br /> | ||
**[[3k96]] – GPDH – ''Coxiella burnetii''<br /> | |||
**[[5ocm]] – GPDH + NADP – ''Streptosporangium roseum''<br /> | |||
*NAD-dependent GPDH or imine reductase | *NAD-dependent GPDH or imine reductase | ||
**[[ | **[[6e8y]], [[1x0v]] – hGPDH-C - human<br /> | ||
**[[6e8z]], [[1x0x]] – hGPDH-C + NAD<br /> | |||
**[[1wpq]] - hGPDH + NAD + DHA<br /> | |||
**[[6e90]] – hGPDH-C + NAD + DHAP<br /> | |||
**[[4fgw]] – GPDH - yeast<br /> | |||
**[[1evy]] – GPDH – ''Leishmania mexicana''<br /> | |||
**[[1n1g]], [[1m66]], [[1m67]], [[1jdj]] – LmGPDH + inhibitor<br /> | |||
**[[1evz]] - LmGPDH + NAD<br /> | |||
**[[1n1e]] – LmGPDH + NAD + DHAP<br /> | |||
}} | }} | ||
==References== | ==References== | ||